Publications by authors named "Miruna F Ates"

Article Synopsis
  • Acute ischemic stroke (AIS) is a serious complication in COVID-19 patients, with a study showing it occurred in 2.31% of hospitalized patients, primarily affecting older individuals with existing health issues.
  • The study analyzed 693 COVID-19 patients from April 2020 to February 2021, revealing that many AIS cases arose within the first 24 hours, led by total anterior circulation infarction and cardioembolic causes.
  • Patients with AIS had a higher prevalence of hypertension and heart disease, with a significant mortality rate, highlighting the need for awareness and monitoring for stroke risks in COVID-19 cases, particularly in older adults.
View Article and Find Full Text PDF

Objective: Assessing the activities of daily living (ADL) is important in cognitive impairment. The everyday cognition scale includes 12 items (ECog-12). It evaluates complex ADLs and executive functions.

View Article and Find Full Text PDF

Objectives: Coronavirus disease 2019 (COVID-19)-related lockdown may have a negative effect on the neuropsychiatric status of Alzheimer's disease (AD) cases. In this study, it was aimed to find future implications by evaluating the neuropsychiatric conditions of AD cases during total and partial lockdown periods.

Methods: It is a prospective, cross-sectional, and multicenter study that includes AD cases which have been followed for at least 1 year by outpatient clinics from different regions of Turkey.

View Article and Find Full Text PDF

Neurological diseases related to coronavirus disease-2019 (COVID-19) are increasingly reported. We report here three cases that presented with subtle neurologic findings manifesting within a range of 15 days to four months after their COVID-19 diagnoses. Magnetic resonance imaging showed acute multifocal periventricular and subcortical demyelinating lesions.

View Article and Find Full Text PDF

Background: Coronavirus disease 2019 (COVID-19) pandemic and lockdown period may induce an impairment in quality of life (QoL), disruption in treatment (DIT), and posttraumatic stress disorder (PTSD) in chronic neurological diseases (CNDs). To reach this information, a multicenter, cross-sectional study (COVQoL-CND) was planned. Parkinson's disease (PD), headache (HA), multiple sclerosis (MS), epilepsy (EP), polyneuropathy (PNP), and cerebrovascular disease (CVD) were selected as the CND.

View Article and Find Full Text PDF

Background/aim: Stigma can be defined as a negative perception of chronically ill patients by their relatives or by society, or a similar self-perception by the patients themselves. We aimed to validate the Turkish version of the Neuroquality of Life (Neuro-QoL)-Stigma Scale for neurologic diseases.

Materials And Methods: Forms were filled out by a total of 152 randomized patients under regular follow-up in the outpatient clinic (29 polyneuropathy, 25 epilepsy, 23 stroke, 24 tension-type headache, 28 multiple sclerosis, 27 Parkinson disease).

View Article and Find Full Text PDF